Sign in

Meritxell Mollà

@meritxellmolla.bsky.social
43 followers 59 following 13 posts

Radiation Oncology. Hospital Clinic Barcelona. Associate Professor Universitat Barcelona

PostsRepliesMedia
Meritxell Mollà @meritxellmolla.bsky.social · 28/09/2025
evidence.nejm.org/doi/full/10....
evidence.nejm.org
Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020
Lung cancer is the leading cause of cancer-related death worldwide. The aim of the KBP-2020 study was to describe survival among patients diagnosed with lung adenocarcinoma in France in 2000, 2010,...
010
Meritxell Mollà @meritxellmolla.bsky.social · 27/07/2025
Costa sud de #Catalunya
020
Meritxell Mollà @meritxellmolla.bsky.social · 24/07/2025
evidence.nejm.org/doi/full/10....
evidence.nejm.org
Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020
Lung cancer is the leading cause of cancer-related death worldwide. The aim of the KBP-2020 study was to describe survival among patients diagnosed with lung adenocarcinoma in France in 2000, 2010,...
000
Reposted by Meritxell Mollà
Matthias Guckenberger @mguckenberger.bsky.social · 25/05/2025
Fresh from #ASCO2025 meetings.asco.org/abstracts-pr... SBRT vs microwave ablation (MWA) in pts with CRC liver oligo-mets ➡️ n=100, n=92 treated (39 SBRT, 53 MWA) ➡️ 18/92 pts (20%) reported side effects ➡️ n=3 G3-4 pain; n=2 infections after open MWA, n=1 bowelperforation after percutaneous MWA
meetings.asco.org
Program Guide – ASCO Meeting Program Guide
152
Meritxell Mollà @meritxellmolla.bsky.social · 02/07/2025
evidence.nejm.org/doi/full/10....
evidence.nejm.org
Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020
Lung cancer is the leading cause of cancer-related death worldwide. The aim of the KBP-2020 study was to describe survival among patients diagnosed with lung adenocarcinoma in France in 2000, 2010,...
010
Meritxell Mollà @meritxellmolla.bsky.social · 20/05/2025
www.catclinart.eu/web/catclina...
catclinart.eu
Clinical Audits in Radiation Oncology: Training for Auditors and Auditees - catclinart - www.catclinart.eu
Clinical Audits in Radiation Oncology: Training for Auditors and Auditees Enhancing Quality and Safety in RadiotherapyWhy Join the Course? Radiotherapy is a critical component of cancer...
010
Meritxell Mollà @meritxellmolla.bsky.social · 23/04/2025
Feliç #santjordi2025
031
Reposted by Meritxell Mollà
International Journal of Radiation Biology @ijrb.bsky.social · 09/01/2025
Melatonin as a radioprotective agent against flattening filter and flattening filter-free beam in radiotherapy-induced lung tissue damage buff.ly/422aw0b #radiation #protection #ijrb
011
Reposted by Meritxell Mollà
Elies Campo @elies.org · 20/11/2024
'What happened in Spain... could happen here' - @ronanfarrow.bsky.social warns as FBI/ICE explore similar spyware. 270K+ views on @cnn.com in <24h shows public interest in understanding these threats—a key step towards building the informed society that makes abuse harder. #Surveilled #CatalanGate
22619
Meritxell Mollà @meritxellmolla.bsky.social · 13/03/2025
t.co/s78m4jtxtG
t.co
https://www.oncolliga.cat/la-valoracio-geriatrica-en-pacients-amb-cancer/
000
Reposted by Meritxell Mollà
Hospital Clínic @hospitalclinic.bsky.social · 10/03/2025
🟣 El #CLÍNIC va atendre 7⃣8⃣4⃣ casos d’agressions sexuals durant el 2024, un 1⃣5⃣% més que el 2023 🏥 L’hospital és el centre de referència en l'atenció de violència sexual recent a la ciutat de Barcelona per a majors de 16 anys ➕Info 👉 www.clinicbarcelona.org/ca/noticies/...
101
Meritxell Mollà @meritxellmolla.bsky.social · 20/02/2025
Save the date🔝🔝
010
Meritxell Mollà @meritxellmolla.bsky.social · 20/02/2025
www.annalsofoncology.org/article/S092...
annalsofoncology.org
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Liver cancer is the sixth most common cancer and the third leading cause of cancer deaths globally.1,2 Hepatocellular cancer (HCC) accounts for 80% of the global liver cancer burden, with >900 000 new...
000
Reposted by Meritxell Mollà
IDIBAPS @idibaps.bsky.social · 03/02/2025
🆕#CampusCLÍNIC creates the Clínic Comprehensive Cancer Center, a structure that integrates care, research, innovation and training in cancer 👉https://s.mtrbio.com/swgyhhmyfy
111
Reposted by Meritxell Mollà
Hospital Clínic @hospitalclinic.bsky.social · 03/02/2025
🆕El #CampusCLÍNIC crea el Clínic Barcelona Comprehensive Cancer Center, una estructura que integra asistencia, investigación, innovación y formación en cáncer bajo un mismo paraguas Está impulsado por #CLÍNIC, @idibaps.bsky.social y @ub.edu. 👉 www.clinicbarcelona.org/noticias/el-...
021
Reposted by Meritxell Mollà
Hospital Clínic @hospitalclinic.bsky.social · 03/02/2025
🆕El #CampusCLÍNIC crea el Clínic Barcelona Comprehensive Cancer Center, una estructura que integra assistència, recerca, innovació i formació en càncer sota un mateix paraigües Està impulsat per #CLÍNIC, @idibaps.bsky.social i @ub.edu 👉 www.clinicbarcelona.org/ca/noticies/...
142
Meritxell Mollà @meritxellmolla.bsky.social · 26/01/2025
ascopubs.org/doi/pdfdirec...
ascopubs.org
000
Reposted by Meritxell Mollà
Hospital Clínic @hospitalclinic.bsky.social · 24/01/2025
🍀Molta sort a tots i totes les estudiants que demà us examineu del MIR, EIR, FIR, BIR, PIR, QIR i RIR.💪 🌟Esteu a punt de començar un camí ple d'aprenentatges que us farà créixer com a professionals i persones. Us esperem, futurs residents del #CLÍNIC! 🩺✨ #residentsCLÍNIC #MIR2025 #MIR25
061
Meritxell Mollà @meritxellmolla.bsky.social · 24/01/2025
www.thegreenjournal.com/article/S016...
thegreenjournal.com
Stereotactic body radiotherapy for non-spine bone metastases: A meta-analysis and international stereotactic radiosurgery society (ISRS) clinical practice guidelines
Bone metastases are common in patients with metastatic solid tumor malignancies and can cause significant morbidity including disabling pain, fracture and hypercalcemia. In the United States, the age-...
000
Meritxell Mollà @meritxellmolla.bsky.social · 23/01/2025
www.sciencedirect.com/science/arti...
sciencedirect.com
Metastasis-directed stereotactic radiotherapy and systemic treatment continuation for patients with oligoprogressive metastatic breast cancer
About 15–20 % of patients with metastatic breast cancer (mBC) can experience oligoprogressive disease (OPD) in ≤ 5 sites of disease. Patients with OPD…
010
Meritxell Mollà @meritxellmolla.bsky.social · 21/01/2025
Here I am
150